80 related articles for article (PubMed ID: 29104782)
1. The Effect of the Targeted Recombinant Toxin DARPin-PE40 on the Dynamics of HER2-Positive Tumor Growth.
Sokolova EA; Proshkina GM; Kutova OM; Balalaeva IV; Deyev SM
Acta Naturae; 2017; 9(3):103-107. PubMed ID: 29104782
[TBL] [Abstract][Full Text] [Related]
2. Recombinant targeted toxin based on HER2-specific DARPin possesses a strong selective cytotoxic effect in vitro and a potent antitumor activity in vivo.
Sokolova E; Proshkina G; Kutova O; Shilova O; Ryabova A; Schulga A; Stremovskiy O; Zdobnova T; Balalaeva I; Deyev S
J Control Release; 2016 Jul; 233():48-56. PubMed ID: 27178808
[TBL] [Abstract][Full Text] [Related]
3. Recombinant Immunotoxin 4D5scFv-PE40 for Targeted Therapy of HER2-Positive Tumors.
Sokolova EA; Stremovskiy OA; Zdobnova TA; Balalaeva IV; Deyev SM
Acta Naturae; 2015; 7(4):93-6. PubMed ID: 26798495
[TBL] [Abstract][Full Text] [Related]
4. Penetration Efficiency of Antitumor Agents in Ovarian Cancer Spheroids: The Case of Recombinant Targeted Toxin DARPin-LoPE and the Chemotherapy Drug, Doxorubicin.
Sokolova E; Kutova O; Grishina A; Pospelov A; Guryev E; Schulga A; Deyev S; Balalaeva I
Pharmaceutics; 2019 May; 11(5):. PubMed ID: 31067739
[TBL] [Abstract][Full Text] [Related]
5. Radioactive (
Guryev EL; Volodina NO; Shilyagina NY; Gudkov SV; Balalaeva IV; Volovetskiy AB; Lyubeshkin AV; Sen' AV; Ermilov SA; Vodeneev VA; Petrov RV; Zvyagin AV; Alferov ZI; Deyev SM
Proc Natl Acad Sci U S A; 2018 Sep; 115(39):9690-9695. PubMed ID: 30194234
[TBL] [Abstract][Full Text] [Related]
6. Selective staining and eradication of cancer cells by protein-carrying DARPin-functionalized liposomes.
Deyev S; Proshkina G; Baryshnikova O; Ryabova A; Avishai G; Katrivas L; Giannini C; Levi-Kalisman Y; Kotlyar A
Eur J Pharm Biopharm; 2018 Sep; 130():296-305. PubMed ID: 29959035
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor receptors in human breast carcinoma cells: a potential selective target for transforming growth factor alpha-Pseudomonas exotoxin 40 fusion protein.
Arteaga CL; Hurd SD; Dugger TC; Winnier AR; Robertson JB
Cancer Res; 1994 Sep; 54(17):4703-9. PubMed ID: 8062268
[TBL] [Abstract][Full Text] [Related]
8. [Cancer gene therapy with plasmid expressing anti-HER2/neu-toxin].
Khodarovich YM; Rakhmaninova DD; Kagarlitskiy GO; Deev SM
Vopr Onkol; 2016; 62(5):671-675. PubMed ID: 30695596
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxicity of targeted HER2-specific phototoxins based on flavoprotein miniSOG is determined by the rate of their internalization.
Shilova ON; Proshkina GM; Ryabova AV; Deyev SM; Petrov RV
Dokl Biochem Biophys; 2017 Jul; 475(1):256-258. PubMed ID: 28864891
[TBL] [Abstract][Full Text] [Related]
10. Comparative Evaluation of Radioiodine and Technetium-Labeled DARPin 9_29 for Radionuclide Molecular Imaging of HER2 Expression in Malignant Tumors.
Vorobyeva A; Bragina O; Altai M; Mitran B; Orlova A; Shulga A; Proshkina G; Chernov V; Tolmachev V; Deyev S
Contrast Media Mol Imaging; 2018; 2018():6930425. PubMed ID: 29977173
[TBL] [Abstract][Full Text] [Related]
11. Highly specific hybrid protein DARPin-mCherry for fluorescent visualization of cells overexpressing tumor marker HER2/neu.
Mironova KE; Chernykh ON; Ryabova AV; Stremovskiy OA; Proshkina GM; Deyev SM
Biochemistry (Mosc); 2014 Dec; 79(12):1391-6. PubMed ID: 25716734
[TBL] [Abstract][Full Text] [Related]
12. Dual Targeting of Cancer Cells with DARPin-Based Toxins for Overcoming Tumor Escape.
Shramova E; Proshkina G; Shipunova V; Ryabova A; Kamyshinsky R; Konevega A; Schulga A; Konovalova E; Telegin G; Deyev S
Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33081407
[TBL] [Abstract][Full Text] [Related]
13. Assessing the use of tumor-specific DARPin-toxin fusion proteins for ex vivo purging of cancer metastases from human ovarian cortex before autotransplantation.
Eijkenboom L; Palacio-Castañeda V; Groenman F; Braat D; Beerendonk C; Brock R; Verdurmen W; Peek R
F S Sci; 2021 Nov; 2(4):330-344. PubMed ID: 35559858
[TBL] [Abstract][Full Text] [Related]
14. DARPin_9-29-Targeted Gold Nanorods Selectively Suppress HER2-Positive Tumor Growth in Mice.
Proshkina GM; Shramova EI; Shilova MV; Zelepukin IV; Shipunova VO; Ryabova AV; Deyev SM; Kotlyar AB
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680384
[TBL] [Abstract][Full Text] [Related]
15. Antitumor activity of a transforming growth factor alpha-Pseudomonas exotoxin fusion protein (TGF-alpha-PE40).
Pai LH; Gallo MG; FitzGerald DJ; Pastan I
Cancer Res; 1991 Jun; 51(11):2808-12. PubMed ID: 2032221
[TBL] [Abstract][Full Text] [Related]
16. Expression of high-affinity interleukin 4 receptors on murine sarcoma cells and receptor-mediated cytotoxicity of tumor cells to chimeric protein between interleukin 4 and Pseudomonas exotoxin.
Puri RK; Ogata M; Leland P; Feldman GM; FitzGerald D; Pastan I
Cancer Res; 1991 Jun; 51(11):3011-7. PubMed ID: 2032239
[TBL] [Abstract][Full Text] [Related]
17. DARPin_9-29-Targeted Mini Gold Nanorods Specifically Eliminate HER2-Overexpressing Cancer Cells.
Proshkina G; Deyev S; Ryabova A; Tavanti F; Menziani MC; Cohen R; Katrivas L; Kotlyar A
ACS Appl Mater Interfaces; 2019 Sep; 11(38):34645-34651. PubMed ID: 31448887
[TBL] [Abstract][Full Text] [Related]
18. Tumor targeting using anti-her2 immunoliposomes.
Park JW; Kirpotin DB; Hong K; Shalaby R; Shao Y; Nielsen UB; Marks JD; Papahadjopoulos D; Benz CC
J Control Release; 2001 Jul; 74(1-3):95-113. PubMed ID: 11489487
[TBL] [Abstract][Full Text] [Related]
19. HER2-Specific Pseudomonas Exotoxin A PE25 Based Fusions: Influence of Targeting Domain on Target Binding, Toxicity, and In Vivo Biodistribution.
Ding H; Altai M; Yin W; Lindbo S; Liu H; Garousi J; Xu T; Orlova A; Tolmachev V; Hober S; Gräslund T
Pharmaceutics; 2020 Apr; 12(4):. PubMed ID: 32344762
[TBL] [Abstract][Full Text] [Related]
20. Internalization and Recycling of the HER2 Receptor on Human Breast Adenocarcinoma Cells Treated with Targeted Phototoxic Protein DARPinminiSOG.
Shilova ON; Proshkina GM; Lebedenko EN; Deyev SM
Acta Naturae; 2015; 7(3):126-32. PubMed ID: 26483969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
